ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物科技指數ETF-iShares Nasdaq
202.93
+0.2900
0.14%
盤後：
203.02
0.0900
+0.04%
19:37 EDT
成交量：
228.63萬
成交額：
4.65億
市值：
102.78億
市盈率：
32.15
高：
205.31
開：
203.94
低：
202.75
收：
202.64
52周最高：
217.12
52周最低：
138.79
股本：
5,065.00萬
流通股本：
5,065.00萬
量比：
1.60
換手率：
4.51%
股息：
0.41
股息率：
0.20%
每股收益(TTM):
6.31
每股收益(LYR):
-1.4940
淨資產收益率：
24.54%
總資產收益率：
0.10%
市淨率：
1.26
市盈率(LYR):
-135.83
資料載入中...
總覽
公司
新聞
公告
巴克萊上調安進目標價至380美元
格隆汇
·
08/17
復宏漢霖擬向山德士授權至多10款生物類似藥，國產生物藥國際化再進一步｜醫藥早參
每日经济新闻
·
08/17
復宏漢霖攜手Sandoz佈局生物類似藥 首批3款產品落地
财中社
·
08/17
復星醫藥：控股子公司與Sandoz AG達成至多10款生物類似藥許可合作，首批3款產品首付款及里程碑款至多2.37億美元
智通财经
·
08/17
Assembly股價上漲，因季度營收超出預期
路透中文
·
08/14
中國銀河證券：實驗動物為創新藥研發剛需 小鼠+猴雙主線高景氣
智通财经
·
08/14
百花醫藥股價嚴重異常波動：主營小分子化學仿製藥CRO業務 不涉及創新藥研發
央广财经
·
08/12
MacroGenics股價上漲，因吉利德支付了1000萬美元的里程碑款項
路透中文
·
08/12
數據簡報-全球製藥企業斥資數十億以擴大在美業務
路透中文
·
08/11
Tango因季度虧損額超出預期而股價下跌
路透中文
·
08/11
百花醫藥(600721.SH)：不涉及創新藥研發
智通财经
·
08/11
百花醫藥(600721.SH)：不涉及創新藥研發
智通财经
·
08/11
東方證券：AI重構創新藥研發底座 國內相關產業鏈公司亦有望受益
智通财经
·
08/11
百濟神州（06160）盤初漲3.94% 與安進聯合開發及商業化的安泰適正式投入臨床使用
金吾财讯
·
08/11
美股異動 | 因競爭對手的藥物研發未達目標 福泰製藥(VRTX.US)漲近7%
智通财经
·
08/10
美股異動 | 因競爭對手的藥物研發未達目標 福泰製藥(VRTX.US)漲近7%
智通财经
·
08/10
福泰製藥(VRTX)股票8月10日開盤上漲9.76%：投資者必看的核心信息
TradingKey中文
·
08/10
數據簡報-全球製藥企業斥資數十億以擴大在美國的市場份額
路透中文
·
08/10
新聞稿：Ernexa Therapeutics 引入資深生物技術高管 David Polinsky 加入董事會，為臨床階段衝刺蓄力
投资观察
·
08/10
Vertex Pharma股價上漲，因競爭對手的遺傳性疾病藥物研發遭遇挫折
路透中文
·
08/10
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/IBB/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":202.93,"timestamp":1789156800000,"preClose":202.64,"halted":0,"volume":2286306,"hourTrading":{"tag":"盘后","latestPrice":203.02,"preClose":202.93,"latestTime":"19:37 EDT","volume":32362,"amount":6567264.34,"timestamp":1789169879648,"change":0.09,"changeRate":0.000444,"amplitude":0.000444},"delay":0,"changeRate":0.0014311093564943766,"floatShares":50650000,"shares":50650000,"eps":6.311863,"marketStatus":"休市中","change":0.29,"latestTime":"09-11 16:00:00 EDT","open":203.94,"high":205.31,"low":202.75,"amount":465174036.47682,"amplitude":0.012633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":202.64,"sharesOutstanding":49450000,"nav":202.867176,"aum":10356369334.8,"dividendRate":0.001997,"bidAskSpread":0.000338,"preHourTrading":{"tag":"盘前","latestPrice":204.63,"preClose":202.64,"latestTime":"09:25 EDT","volume":602,"amount":123106.38130000001,"timestamp":1789133112066,"change":1.99,"changeRate":0.00982,"amplitude":0.017917},"postHourTrading":{"tag":"盘后","latestPrice":203.02,"preClose":202.93,"latestTime":"19:37 EDT","volume":32362,"amount":6567264.34,"timestamp":1789169879648,"change":0.09,"changeRate":0.000444,"amplitude":0.000444},"volumeRatio":1.6013834487935477,"impliedVol":0.2368,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50650000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":1.6013834487935477,"shares":50650000,"dividePrice":0.4053,"high":205.31,"amplitude":0.012633,"preClose":202.64,"low":202.75,"week52Low":138.785,"pbRate":"1.26","psRate":"247.29","week52High":217.12,"institutionHeld":0,"latestPrice":202.93,"eps":6.311863,"divideRate":0.001997,"volume":2286306,"delay":0,"ttmEps":6.311863,"open":203.94,"prevYearClose":168.77,"prevWeekClose":211.92,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":213.81,"twentyDayClose":198.94,"sixtyDayClose":171.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660101358","title":"巴克萊上調安進目標價至380美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101358","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660101358?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 11:05","pubTimestamp":1786935953,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1061106388.HKD","LU0320765992.SGD","IE0009355771.USD","IBB","LU2242652126.USD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0058720904.USD","AMGN","LU2112291526.USD","BK4139","BK4534","LU1057294990.SGD","BK4566","IE0002141913.USD","LU0889565916.HKD","IE00B2B36J28.USD","UDN","LU0868494617.USD","LU1571399168.USD","LU2089984988.USD","PJP","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU2468319806.SGD","BIB","BK4585","LU0289739699.SGD","SG9999001440.SGD","BK4581","TBXU","UUP","BK4599","LU0122379950.USD","LU1023059063.AUD","BK4588","IBBQ","LU2242646821.SGD","BK4533","PBE","LU1983299246.USD","BBH","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660106203","title":"復宏漢霖擬向山德士授權至多10款生物類似藥，國產生物藥國際化再進一步｜醫藥早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2660106203","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660106203?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 09:33","pubTimestamp":1786930438,"startTime":"0","endTime":"0","summary":"过去一周（截至8月14日收盘），创新药板块震荡上行。打包医药全产业链的医药ETF（512120）上涨0.2%，聚焦A股创新药的生物医药ETF（159508）上涨1.77%，聚焦港股创新药的港股通生物科技ETF（159102）上涨0.12%。相关个股中，康龙化成上涨8.48%、药明康德上涨2.85%、恒瑞医药下跌3.66%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173842706171.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173842706171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2272731782.SGD","BK4585","IE00B5TLWC47.USD","HK0000320223.HKD","LU2322448957.HKD","BK1515","LU2322448791.USD","IBB","XPH","159839","BK1574","PPH","BK1161","LU1992135399.USD","LU1992135472.HKD","LU2473716301.USD","LU2272731600.USD","HK0000320264.USD","02696","09939","LU2272731865.HKD","159938","BK4588","HK0000165453.HKD","HK0000306685.HKD","HK0000306701.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660110620","title":"復宏漢霖攜手Sandoz佈局生物類似藥 首批3款產品落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2660110620","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660110620?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 09:22","pubTimestamp":1786929720,"startTime":"0","endTime":"0","summary":"8月17日，复宏汉霖（02696）发布公告，公司于2026年8月16日与SandozAG达成战略合作框架协议，预计2026年可实现的开票金额总计不超过1.01亿元美元。此次合作开发最多10款单抗和/或ADC生物类似药相关产品，后续针对各个产品另行签订附属协议确定具体合作条款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608173842662937.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608173842662937.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2272731600.USD","BK4585","PPH","IE00B5TLWC47.USD","HK0000320264.USD","HK0000320223.HKD","HK0000165453.HKD","LU2272731865.HKD","02696","HK0000306685.HKD","IBB","LU1992135399.USD","LU2322448791.USD","BK1161","LU1992135472.HKD","BK4588","LU2322448957.HKD","HK0000306701.USD","LU2272731782.SGD","LU2473716301.USD","XPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660219103","title":"復星醫藥：控股子公司與Sandoz AG達成至多10款生物類似藥許可合作，首批3款產品首付款及里程碑款至多2.37億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660219103","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660219103?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 07:48","pubTimestamp":1786924110,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2272731865.HKD","SILJ","LU2272731782.SGD","IE00B5TLWC47.USD","LU2322448957.HKD","BK4585","SLJY","LU2473716301.USD","LU1992135399.USD","LU1992135472.HKD","XPH","IBB","AG","BK4210","SLVX","LU2272731600.USD","SLVR","BK4588","PPH","LU2322448791.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659400001","title":"Assembly股價上漲，因季度營收超出預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2659400001","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659400001?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 23:25","pubTimestamp":1786721141,"startTime":"0","endTime":"0","summary":"BUZZ-Assembly股价上涨，因季度营收超出预期8月14日-** 药物研发公司Assembly Biosciences（ASMB.O）股价上涨4.6%，报31.32美元** ASMB第二季度与吉利德（GILD.O）合作研究的收入为1340万美元，高于去年同期的960万美元** 据LSEG数据显示，分析师此前平均预期营收为860万美元** 公司表示，营收增长包括针对吉利德合作项目下未来活动最新预估所作的510万美元补足调整** 报告显示第二季度每股亏损20美分，而市场预期为每股亏损65美分** 计入当日涨幅后，该股年初至今累计上涨11.8%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL4S44B103:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","LU0965509283.SGD","ASMB","BK4585","LU0889565916.HKD","LU0114720955.EUR","BIB","BK4532","LU2468319806.SGD","TMED","BK4568","IE00BZ1G4Q59.USD","BK4588","LU1037948897.HKD","MEDI","BK4550","LU0058720904.USD","LU0965509101.SGD","LU1037948541.HKD","LU0861579265.USD","LU2087621335.USD","LU1066051498.USD","BK4566","IE00B19Z3581.USD","LU1061106388.HKD","LU1585245621.USD","LU1934455277.USD","SG9999015986.USD","BK4578","LU0109394709.USD","SG9999015945.SGD","BK4583","SG9999015952.SGD","LU2112291526.USD","IE00B3T34201.USD","IBB","GILD","LU1839511570.USD","IE00BSNM7G36.USD","BBH","LU0965508806.USD","LU1066053197.SGD","BK4139","LU2324357040.USD","TBXU","LU0289739699.SGD","LU0234570918.USD","IBBQ","LU0122379950.USD","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659504119","title":"中國銀河證券：實驗動物為創新藥研發剛需 小鼠+猴雙主線高景氣","url":"https://stock-news.laohu8.com/highlight/detail?id=2659504119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659504119?lang=zh_tw&edition=fundamental","pubTime":"2026-08-14 15:07","pubTimestamp":1786691225,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国银河证券发布研报称，实验动物为创新药研发刚需，行业壁垒深厚，两大细分赛道具备中长期成长逻辑：人源化小鼠赛道成长确定性更强、周期波动平缓;实验猴赛道供给约束强，短期价格上行带来显著业绩弹性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBB","BK0188","GSKH","WRND","601881","BK4588","XLVI","GDOC","BK1564","SBIO","LFSC","161027","BK4585","BK0276","BIOY","BK1147","06881","BBP","APXH","PBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903675","title":"百花醫藥股價嚴重異常波動：主營小分子化學仿製藥CRO業務 不涉及創新藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903675","media":"央广财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903675?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 21:27","pubTimestamp":1786541220,"startTime":"0","endTime":"0","summary":"8月12日，百花医药（维权）（600721.SH）发布公告称，公司股票连续10个交易日内日收盘价格涨幅偏离值累计超过100%，根据上交所的有关规定，属于股票交易严重异常波动情形。公司是以小分子化学仿制药研发为主的CRO企业，不涉及创新药研发。公司2026年第一季度实现营业收入6718.29万元，同比下降30.68%，归属于上市公司股东的净利润664.27万元，同比下降67.94%。目前公司主营业务未发生重大变化，市场环境、行业政策没有发生重大调整，股价短期内连续上涨，涨幅与公司经营情况严重偏离。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-12/doc-ininamih5206238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["GSKH","600721","APXH","SBIO","BK0216","WRND","BK0102","IBB","BIOY","BK4585","XLVI","BBP","BK4588","PBE","LFSC","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658465479","title":"MacroGenics股價上漲，因吉利德支付了1000萬美元的里程碑款項","url":"https://stock-news.laohu8.com/highlight/detail?id=2658465479","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658465479?lang=zh_tw&edition=fundamental","pubTime":"2026-08-12 05:18","pubTimestamp":1786483082,"startTime":"0","endTime":"0","summary":"BUZZ-MacroGenics股价上涨，因吉利德支付了1000万美元的里程碑款项8月11日-** 药物开发商MacroGenics（MGNX.O）的股价在盘后交易中上涨3.8%，至4.07美元** 该公司表示，根据其与吉利德（GILD.O）就一项临床前双特异性项目（一种癌症疗法）达成的许可协议，已收到1000万美元的里程碑付款** 根据2022年签署的合作协议，MacroGenics与吉利德正在推进三个项目：处于临床阶段的抗癌疗法MGD024，以及两个处于临床前阶段的双特异性项目** MGNX仍有资格获得最高约16亿美元的额外开发、监管及商业里程碑付款** 今年以来，该公司股价已翻了一番多","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4S4481IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","GILD","LU0965509101.SGD","LU1778281490.HKD","TMED","SG9999015945.SGD","SG9999015952.SGD","BK4550","IE00B7SZLL34.SGD","LU1585245621.USD","BK4566","BK4585","LU0234570918.USD","IE00B19Z3B42.SGD","SG9999015978.USD","IE00BSNM7G36.USD","LU0965508806.USD","BBH","IE00BZ1G4Q59.USD","BMED","LU2087621335.USD","LU1430594728.SGD","LU2324357040.USD","BK4532","LU0882574055.USD","LU2089984988.USD","LU1839511570.USD","LU1934455277.USD","SG9999015986.USD","IBB","LU0114720955.EUR","BK4588","IBBQ","LU1674673428.USD","MEDI","TBXU","MGNX","LU1023059063.AUD","LU1066051498.USD","LU1934455863.HKD","BIB","BK4578","IE00B19Z3581.USD","LU0058720904.USD","BK4139","IE0002270589.USD","LU1674673691.USD","IE00BKVL7J92.USD","LU0289739699.SGD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658591102","title":"數據簡報-全球製藥企業斥資數十億以擴大在美業務","url":"https://stock-news.laohu8.com/highlight/detail?id=2658591102","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658591102?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:59","pubTimestamp":1786463961,"startTime":"0","endTime":"0","summary":"数据简报-全球制药企业斥资数十亿以扩大在美业务更新了第18段中关于百健生产工厂的数据路透8月11日-全球制药企业正扩大在美国的业务布局，承诺投入数十亿美元以提升该国的生产能力和研发实力。该公司于6月表示，已在佛罗里达州杰克逊维尔投资约10亿美元，以加强其眼科护理业务在美国的制造能力。这家制药公司宣布将投资 6.5 亿美元 ，以扩大其位于波多黎各洪科斯工厂的药品生产规模，此举预计将创造近 750 个就业岗位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4S448167:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B894F039.SGD","LU2023250504.SGD","LU1221951046.USD","LU1037948897.HKD","LU2089284900.SGD","LU0471298694.HKD","LU2462157665.USD","LU0174119429.USD","LU1228905037.USD","SG9999015986.USD","LU0792757196.USD","LU0124676726.USD","LU1066051225.USD","LU1280957306.USD","LU0029864427.USD","VHT","LU0345770308.USD","BK4559","LU0511384066.AUD","SG9999014559.SGD","LU0265550946.USD","LU2357627491.SGD","LU1244550221.USD","SG9999011175.SGD","LU2403377893.USD","MRK","LU2746668461.USD","SG9999002224.SGD","LU1868836757.USD","LU1917777945.USD","LU0353189680.USD","LU0130517989.USD","LU0133085943.USD","IE00BGHQF631.EUR","LU0882574055.USD","LU1261432733.SGD","LU1037948541.HKD","LU0096364046.USD","LU1121112475.USD","BMY","LU0354030511.USD","BK4592","LU0109394709.USD","LU1732799900.SGD","IE00B19Z3581.USD","SG9999014906.USD","LU1868836591.USD","IE00B3PB1722.GBP","LU0306806265.USD","SG9999001176.USD","LU0211327993.USD","IE00BKVL7J92.USD","LU0943347566.SGD","IE00BJJMRX11.SGD","LU1267930573.SGD","LU0795875086.SGD","LU2491049909.HKD","LU0321505868.SGD","LU2129689605.HKD","SG9999013999.USD","LU1496350171.SGD","LU1032955483.USD","LU1934455277.USD","LU1551013425.SGD","IE000BZT7R73.USD","LU1043141123.HKD","LU0098860793.USD","CURE","LU1228905540.USD","LU0949170772.SGD","LU0289739699.SGD","LU1162221912.USD","PFE","LU2211815571.USD","BK4516","LU1941712348.USD","LU1116320901.HKD","XLV","AZN","LU2237443978.SGD","LU0266013472.USD","LU2491050154.USD","BK4532","IE00BLSP4452.SGD","IE0001KFT4U8.USD","SG9999014898.SGD","LU1064131342.USD","SGXZ81514606.USD","LU0820561909.HKD","LU2125154935.USD","LU2461242641.AUD","LU0170899867.USD","LU1935042991.SGD","LLYX","LU0267386448.USD","IE00BN29S564.USD","LU0097036916.USD","LU1069347547.HKD","LU0689626769.HKD","LU2552382058.USD","IE000MB6IJN5.SGD","IE00BN8TJ469.HKD","LU1868837300.USD","IE00BDGV0183.EUR","IE00BK4W5M84.HKD","LU0965509283.SGD","IE00BKDWB100.SGD","LU2111349929.HKD","LU1629891620.HKD","LU1623119135.USD","IE000M9KFDE8.USD","BK7508","BK4566","LU1720051108.HKD","LU2361045086.USD","LU2361044949.HKD","LU0672654240.SGD","LU0072461881.USD","GDOC","LU1718418525.SGD","IXJ","04332","LU1267930730.SGD","LU1894683264.USD","LU0471298777.SGD","IE00BBT3K403.USD","LU0320765992.SGD","LU1923622614.USD","IE00B1XK9C88.USD","SG9999015358.SGD","MEDX","LU2087625088.SGD","LU1934455863.HKD","IE00B19Z9P08.USD","LU2756315318.SGD","IHE","IE0004445239.USD","LU0321505439.SGD","LU0162691827.USD","LU0545039389.USD","BK4504","LU1670711123.USD","LU2023250843.SGD","LU2023251221.USD","LU2236285917.USD","SGXZ99366536.SGD","LU0203202063.USD","LU2505996509.AUD","LU1059921491.USD","LU1035773651.USD","IE00BKPKM429.USD","SG9999001176.SGD","LU0965509010.AUD","LU0130102774.USD","LU2596442595.SGD","LU1670710661.SGD","IE00B19Z9Z06.USD","LU0211331839.USD","JNJ","LU1069344957.HKD","LU1868836914.USD","LU2129689514.USD","LU2237443549.SGD","IE00BFSS7M15.SGD","LU1720051017.SGD","LU2471134952.CNY","LU2168564222.USD","LU1221951129.SGD","LU2168564065.EUR","LU2433249047.HKD","LU2168564149.EUR","IBBQ","LU0225283273.USD","LU0225284248.USD","LU2746668974.SGD","LU1061106388.HKD","THNR","LU0353189763.USD","LU1244550494.USD","LU0823434740.USD","SG9999018865.SGD","LU0965508806.USD","BK4534","SG9999002232.USD","LU1929549753.HKD","AMGN","LU1116320737.USD","LU0058720904.USD","LU0198837287.USD","LU1829250122.USD","LU2237443895.HKD","LU1323610961.USD","LU0114720955.EUR","LU0345770993.USD","LU2237443465.HKD","LU2087621335.USD","LU1496350502.SGD","LU0345769631.USD","LU0158827948.USD","LU0106261372.USD","LU0708995401.HKD","LU2360032135.SGD","LU1699723380.USD","LU1674673428.USD","IE00BSNM7G36.USD","LU2108987350.USD","SG9999014914.USD","LU0122379950.USD","TBXU","LU2089283258.USD","LU0456855351.SGD","LU1868837136.USD","LU2592432038.USD","LU0868494708.USD","LU2168563687.JPY","LU0795875169.SGD","LU1804176565.USD","BK4139","LU2361044865.SGD","LU0320765646.SGD","LU2237443622.USD","LU2462591350.SGD","IE00B7KXQ091.USD","LU2264538146.SGD","LU0203201768.USD","LU2242652126.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","LU2552382132.HKD","LU0208291251.USD","LU0868494617.USD","IE00B1BXHZ80.USD","LU0203345920.USD","IE0004445015.USD","BMED","SGXZ51526630.SGD","SG9999001440.SGD","LU0094547139.USD","GILD","BK4585","LU1670627923.USD","LU0234572021.USD","LU2242646821.SGD","LU0210536198.USD","BBH","LU0320765489.SGD","LU2417539215.USD","LU0820561818.USD","BK4578","LU0310800379.SGD","CANC","LU1712237335.SGD","LU2237443382.USD","LU1989772923.USD","LU0477156953.USD","LU0354030438.USD","LLY","IE00BVYPNV92.GBP","IE0005OL40V9.USD","LU1066051498.USD","IE0000B7K699.USD","SG9999015952.SGD","LU2125909593.SGD","WDNA","LU1057294990.SGD","LU0965509101.SGD","LU0786609619.USD","BK4583","LLYZ","LU1914381329.SGD","LU0211328371.USD","IE00BJT1NW94.SGD","LU0053666078.USD","LU1894683348.USD","LU2133065610.SGD","LU0316494557.USD","LU0787776722.HKD","SG9999014575.USD","LU0689472784.USD","BK7511","LU2750360997.AUD","IE00BFSS8Q28.SGD","LU1506573853.SGD","CSL.AU","IE00BFTCPJ56.SGD","OZEM","SG9999018857.SGD","LU0256863811.USD","SG9999014542.SGD","IE00BZ1G4Q59.USD","JDOC","LU2471134796.USD","LU1670628061.USD","MHIP","IE00B7SZLL34.SGD","LU0861579265.USD","LU0306807586.USD","LU2089984988.USD","LU0061475181.USD","BK4599","LU0726765562.USD","IE000SO60NU8.SGD","LU0553294199.USD","IE00B19Z3B42.SGD","LU0238689110.USD","LU0385154629.USD","LU0889566641.SGD","LU0265550359.USD","LU2357305700.SGD","SG9999017495.SGD","LU1267930490.SGD","BK4533","LU2750360641.GBP","LU2430703095.HKD","LU2491050071.SGD","LU1023059063.AUD","LU1670711040.USD","IE00B4JS1V06.HKD","LU1291159041.SGD","IE000WAW04H5.SGD","LU2602419157.SGD","FHLC","IE0002270589.USD","IE00B3T34201.USD","LU0882574139.USD","LU0256863902.USD","LU0417517546.SGD","LU0823434583.USD","LU2430703178.SGD","LU1988902786.USD","IE000F7OJYX1.SGD","LU0070217475.USD","AGNG","LU2265009873.SGD","RXL","AZNH","LU1732800096.USD","IBB","BK7067","IE00BFXG1179.USD","LU0426417589.USD","SG9999015978.USD","LU0310799852.SGD","LU1989771016.USD","BIIB","LU1267930813.SGD","LU1145028129.USD","SG9999015945.SGD","LU1430594728.SGD","PAWZ","GB00BDT5M118.USD","SG9999014567.USD","LU2129689431.USD","MEDI","LU0323591593.USD","LU0203347892.USD","LU1941712264.USD","LU0079474960.USD","LU0128525929.USD","ELIL","LU0648001328.SGD","LU1127390331.HKD","ILDR","LU0472753341.HKD","LU2112291526.USD","LU1674673691.USD","LU0820562030.AUD","BK4007","LU0994945656.USD","LU0889565916.HKD","LU1989772840.SGD","LU1093756325.SGD","LU2347655156.SGD","GLAM","LU1032466523.USD","LU0237698245.USD","LU1983299246.USD","SG9999015341.SGD","LU0683600562.USD","LU1814569148.SGD","IE00BWXC8680.SGD","LU0006306889.USD","LU2106854487.HKD","LU1934455194.USD","LU0912757837.SGD","LU1571399168.USD","BK4550","LU0225771236.USD","SG9999003800.SGD","LU1035775433.USD","LU2324357040.USD","LU0964807845.USD","IE0009355771.USD","SGXZ57979304.SGD","LU0661504455.SGD","TMED","LU2471134879.HKD","LU0069063385.USD","LU2237438978.USD","LU0320765059.SGD","LU1066053197.SGD","TRUH","IE00BJJMRY28.SGD","LU0070302665.USD","LU0109391861.USD","LU0426412945.USD","LU0210528500.USD","LU1196500208.SGD","PPH","FTXH","IE00BLSP4239.USD","LLII","LU0466842654.USD","LU2063271972.USD","ELIS","LU2347655073.USD","LU2213496289.HKD","LU1066051811.HKD","LU1201861249.SGD","LU0985320562.USD","LU2125909247.SGD","LU0980610538.SGD","LU2028103732.USD","BK4588","LU1585245621.USD","LU0345769128.USD","IE00BVYPNW00.USD","LU0640476718.USD","LU0545562505.USD","LU0289961442.SGD","LU2168564495.EUR","LU0738911758.USD","SGXZ80539844.SGD","PBE","LU1043141396.HKD","LU2505996681.GBP","LU2756315664.SGD","LU2468319806.SGD","LU1074936037.SGD","LU0823416689.USD","LU1366192091.USD","ABBV","LU2552382215.SGD","LU0057025933.USD","IE00BK4W5L77.USD","LU1974910355.USD","LU0289739343.SGD","LU0708994859.HKD","BK4581","IE0002141913.USD","IE0034235303.USD","LU2430703251.USD","LU1839511570.USD","LU2125154778.USD","LU0395794307.EUR","BK7501","LU2023250330.USD","IE00B775H168.HKD","SGXZ31699556.SGD","LU1551013342.USD","LU0234570918.USD","IE00B42XCP33.USD","LU2487616109.SGD","HRTS","LU0158827781.USD","PJP","LU1093756168.USD","LU1670710588.SGD","SG9999014880.SGD","LU1778281490.HKD","IE00B2B36J28.USD","LU1883839398.USD","BIB","LU1979441026.SGD","LU2896262040.SGD","LU2271345857.HKD","LU1244550577.SGD","BK4568","LU2360106947.USD","LU1003077747.HKD","LU1232071149.USD","LU0942090050.USD","LU2471134523.USD","LU0859254822.USD","LU2456880835.USD","IE00B4R5TH58.HKD","LU0985481810.HKD","LU1548497426.USD","IE00BJLML261.HKD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658391156","title":"Tango因季度虧損額超出預期而股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2658391156","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658391156?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 23:19","pubTimestamp":1786461555,"startTime":"0","endTime":"0","summary":"BUZZ-Tango因季度亏损额超出预期而股价下跌8月11日-** 药物研发公司Tango TherapeuticsTNGX.O股价下跌3.3%，报26.75美元** 据LSEG数据显示，该公司报告第二季度每股亏损37美分，而分析师平均预期为每股亏损31美分** TNGX报告称，截至2026年6月30日的三个月内未产生合作收入，原因是与吉利德GILD.O的合作关系及研发活动已终止** 该公司202","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4T44814U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU1674673691.USD","IE0002270589.USD","LU0320765992.SGD","LU1934455277.USD","IE0009355771.USD","RVMD","IBB","IE00B7SZLL34.SGD","LU0109394709.USD","IE00BZ1G4Q59.USD","IE00BJT1NW94.SGD","BK4532","LU1066053197.SGD","BK4139","LU1934455863.HKD","TNGX","LU1674673428.USD","LU0965509010.AUD","LU0889565916.HKD","IE00B2B36J28.USD","IE00B19Z3581.USD","LU2089984988.USD","IDNA","IE00B4R5TH58.HKD","LU2468319806.SGD","BIB","LU0114720955.EUR","BK4585","LU0289739699.SGD","LU2324357040.USD","LU0861579265.USD","LU1037948897.HKD","TBXU","PTH","LU0965508806.USD","LU1778281490.HKD","SG9999015952.SGD","TMED","BK4588","BMED","GILD","IBBQ","CANC","LU0234570918.USD","LU2087621335.USD","BBH","IE00BJJMRZ35.SGD","BK4583","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658692990","title":"百花醫藥(600721.SH)：不涉及創新藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2658692990","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658692990?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 20:03","pubTimestamp":1786449780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["APXH","BK4588","GDOC","IBB","BIOY","GSKH","BBP","WRND","PBE","XLVI","BK4585","LFSC","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658667990","title":"百花醫藥(600721.SH)：不涉及創新藥研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2658667990","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658667990?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 20:03","pubTimestamp":1786449780,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百花医药(600721.SH)发布股票交易风险提示公告称，公司是以小分子化学仿制药研发为主的CRO企业，主营业务是为客户提供小分子化仿药为主的药物研发注册“一站式”全流程服务，主要研发项目多来自于客户委托加部分的公司自主立项，不涉及创新药研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["XLVI","PBE","APXH","BK0216","IBB","BK4585","GDOC","600721","WRND","BK0102","BBP","BIOY","GSKH","BK4588","SBIO","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658962968","title":"東方證券：AI重構創新藥研發底座 國內相關產業鏈公司亦有望受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2658962968","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658962968?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 14:06","pubTimestamp":1786428403,"startTime":"0","endTime":"0","summary":"东方证券主要观点如下：技术颠覆成本，AI重构制药“快与省”是中国创新药崛起的底层逻辑，根基是人才红利和成本优势。专家与AI协同，将真正提升新药研发的成功率并缩短周期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["APXH","BK0188","BK4585","BK0183","AIPO","ARTY","BK1564","AGIX","BK1147","600958","BIOY","IBB","XLVI","BK0276","PBE","VTHR","LFSC","WRND","BK0028","GSKH","BK4588","GDOC","SBIO","QTOC","03958","BK0012","CHAT","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658196566","title":"百濟神州（06160）盤初漲3.94% 與安進聯合開發及商業化的安泰適正式投入臨床使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2658196566","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658196566?lang=zh_tw&edition=fundamental","pubTime":"2026-08-11 09:39","pubTimestamp":1786412383,"startTime":"0","endTime":"0","summary":"金吾财讯 | 百济神州 盘初上涨3.94%，最新报221.60港元，成交额1.86亿港元。消息面上，百济神州8月11日早上宣布，由百济神州与安进公司共同负责在中国开发和商业化的安泰适正式投入临床使用。此外，8月10日，百济神州宣布与Revolution Medicines达成一项多方面合作协议。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/OTEzM2QyMzQzMjc2MzA3OTk2MA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987884","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","LU1969619763.USD","LU0109394709.USD","BK1161","AMGN","IE00B4R5TH58.HKD","LU0122379950.USD","LU1571399168.USD","688235","PBE","LU0828237510.HKD","LU2112291526.USD","BK4533","LU0058720904.USD","LU0307460666.USD","LU2468319806.SGD","LU2089984988.USD","PJP","BK4588","IBB","LU1057294990.SGD","ONC","LU2242652126.USD","LU0289739699.SGD","LU1061106388.HKD","LU0228659784.USD","KURE","LU1770034418.SGD","SG9999001440.SGD","TBXU","BK1583","BK1500","BK4566","LU1983299246.USD","IE0002141913.USD","LU0588546209.SGD","BK4139","LU2242646821.SGD","BBH","BIB","BK4526","IBBQ","IE00B2B36J28.USD","IE0009355771.USD","06160","IE00BJT1NW94.SGD","BK4599","BK4534","BK4585","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658930620","title":"美股異動 | 因競爭對手的藥物研發未達目標 福泰製藥(VRTX.US)漲近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658930620","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658930620?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 23:39","pubTimestamp":1786376356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["VRTX","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0256863811.USD","IE00BFTCPJ56.SGD","LU1035775433.USD","IBBQ","LU0058720904.USD","LU1585245621.USD","LU0889565916.HKD","PBE","IE00BZ9MQY76.HKD","LU2089984988.USD","BBH","BK4585","LU0289739699.SGD","IE0009355771.USD","LU2236285917.USD","LU1674673691.USD","IE00B19Z3581.USD","IBB","LU2417539215.USD","SG9999013999.USD","BK4567","IE00B19Z9Z06.USD","LU1778281490.HKD","TBXU","BK4139","LU1093756168.USD","GNMX","LU2324357040.USD","LU2362541513.USD","SGXZ57979304.SGD","IDNA","LU1430594728.SGD","LU2456880835.USD","LU0417517546.SGD","LU1069344957.HKD","LU1674673428.USD","BK4588","SG9999001176.USD","LU2462157665.USD","SG9999001176.SGD","IBBJ","IE00B19Z9P08.USD","IE0002270589.USD","LU0234570918.USD","LU2362540622.SGD","IE0002141913.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658793062","title":"美股異動 | 因競爭對手的藥物研發未達目標 福泰製藥(VRTX.US)漲近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658793062","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658793062?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 23:39","pubTimestamp":1786376356,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周一，$福泰制药(VRTX)$(VRTX.US)早盘涨近7%，创历史新高;而竞争对手$Sionna Therapeutics(SION)$(SION.US)暴跌超90%，创记录新低。消息面上，SION表示，由于SION-719实验性囊性纤维化药物在中期临床试验中未能达到主要目标，公司将终止该药物的研发。投资者此前一直担忧SION可能对VRTX的核心囊性纤维化业务构成威胁，但此次试验失败消除了这一担忧。VRTX公司销售的Trikafta和Alyftrek用于治疗囊性纤维化——这是一种罕见、慢性且会缩短寿命的遗传性疾病，会导致肺部进行性损伤。","market":"us","thumbnail":"https://static.tigerbbs.com/f156a54f9e4928ab062a3cdbe13dd440","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f156a54f9e4928ab062a3cdbe13dd440"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478244.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1674673428.USD","IE00BJJMRZ35.SGD","LU1778281490.HKD","BBH","LU0417517546.SGD","LU2468319806.SGD","BIB","LU1430594728.SGD","LU1093756168.USD","LU2362541273.HKD","SGXZ57979304.SGD","LU1585245621.USD","LU0058720904.USD","BK4532","LU0234570918.USD","LU1674673691.USD","IE00B19Z9Z06.USD","LU2456880835.USD","IBB","IE00BZ9MQY76.HKD","SG9999001176.SGD","LU0320765992.SGD","VRTX","PBE","IE00BFTCPJ56.SGD","LU2236285917.USD","LU0061475181.USD","LU2462157665.USD","LU0079474960.USD","IE0002141913.USD","SG9999001176.USD","SG9999013999.USD","LU2417539215.USD","LU0109394709.USD","IDNA","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU2362541513.USD","BK4139","IBBJ","IBBQ","TBXU","GNMX","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0256863811.USD","IE00B4R5TH58.HKD","IE00B19Z3581.USD","IE00B894F039.SGD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658934147","title":"福泰製藥(VRTX)股票8月10日開盤上漲9.76%：投資者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2658934147","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658934147?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 21:48","pubTimestamp":1786369694,"startTime":"0","endTime":"0","summary":"• 福泰制药（Vertex）公布了其非阿片类疼痛治疗候选药物的积极III期临床数据。\n• 在产品于国际市场成功上市后，该公司上调了全年营收指引。\n• 分析师维持“买入”评级，平均目标价为557.64美元。","market":"hk","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262092811-market-movers-vrtx-20260810","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","IE0002141913.USD","BK4139","GNMX","IE00BJT1NW94.SGD","TBXU","IDNA","LU1093756325.SGD","BIB","BBH","LU1430594728.SGD","SG9999001176.SGD","LU2089984988.USD","BK4533","LU0061475181.USD","LU2324357040.USD","LU2236285917.USD","LU2362541273.HKD","LU0320765992.SGD","BK4567","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU1035775433.USD","IE00BJJMRZ35.SGD","BK4532","IE00B19Z3581.USD","LU1585245621.USD","LU0889565916.HKD","VRTX","LU0432979614.USD","BK4588","IBBQ","SG9999013999.USD","BK4585","LU2362540622.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","LU2456880835.USD","IBB","LU0234570918.USD","LU0256863811.USD","IE0002270589.USD","LU1778281490.HKD","LU2237438978.USD","LU2462157665.USD","LU0823416689.USD","SG9999001176.USD","LU2362541513.USD","PBE","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931998","title":"數據簡報-全球製藥企業斥資數十億以擴大在美國的市場份額","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931998","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931998?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 21:18","pubTimestamp":1786367928,"startTime":"0","endTime":"0","summary":"数据简报-全球制药企业斥资数十亿以扩大在美国的市场份额修改发稿日期，补充百时美施贵宝的投资计划路透8月10日-全球制药企业正扩大在美国的业务布局，承诺投入数十亿美元以提升该国的生产能力和研发实力。该公司于6月表示，已在佛罗里达州杰克逊维尔投资约10亿美元，以加强其眼科护理业务在美国的制造能力。赛诺菲计划通过直接投资公司现有基地以及与其他国内制造商建立合作伙伴关系，扩大其在美国的生产能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4T4470YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B894F039.SGD","LU2023250504.SGD","LU1221951046.USD","LU1037948897.HKD","LU2089284900.SGD","LU0471298694.HKD","LU2462157665.USD","LU0174119429.USD","LU1228905037.USD","SG9999015986.USD","LU0792757196.USD","LU0124676726.USD","LU1066051225.USD","LU1280957306.USD","LU0029864427.USD","VHT","LU0345770308.USD","BK4559","LU0511384066.AUD","SG9999014559.SGD","LU0265550946.USD","LU2357627491.SGD","LU1244550221.USD","SG9999011175.SGD","LU2403377893.USD","MRK","LU2746668461.USD","SG9999002224.SGD","LU1868836757.USD","LU1917777945.USD","LU0353189680.USD","LU0130517989.USD","LU0133085943.USD","IE00BGHQF631.EUR","LU0882574055.USD","LU1261432733.SGD","LU1037948541.HKD","LU0096364046.USD","LU1121112475.USD","BMY","LU0354030511.USD","BK4592","LU0109394709.USD","LU1732799900.SGD","IE00B19Z3581.USD","SG9999014906.USD","LU1868836591.USD","IE00B3PB1722.GBP","LU0306806265.USD","SG9999001176.USD","LU0211327993.USD","IE00BKVL7J92.USD","LU0943347566.SGD","IE00BJJMRX11.SGD","LU1267930573.SGD","LU0795875086.SGD","LU2491049909.HKD","LU0321505868.SGD","LU2129689605.HKD","SG9999013999.USD","LU1496350171.SGD","LU1032955483.USD","LU1934455277.USD","LU1551013425.SGD","IE000BZT7R73.USD","LU1043141123.HKD","LU0098860793.USD","CURE","LU1228905540.USD","LU0949170772.SGD","LU0289739699.SGD","LU1162221912.USD","PFE","LU2211815571.USD","BK4516","LU1941712348.USD","LU1116320901.HKD","XLV","AZN","LU2237443978.SGD","LU0266013472.USD","LU2491050154.USD","BK4532","IE00BLSP4452.SGD","IE0001KFT4U8.USD","SG9999014898.SGD","LU1064131342.USD","SGXZ81514606.USD","LU0820561909.HKD","LU2125154935.USD","LU2461242641.AUD","LU0170899867.USD","LU1935042991.SGD","LLYX","LU0267386448.USD","IE00BN29S564.USD","LU0097036916.USD","LU1069347547.HKD","LU0689626769.HKD","LU2552382058.USD","IE000MB6IJN5.SGD","IE00BN8TJ469.HKD","LU1868837300.USD","IE00BDGV0183.EUR","IE00BK4W5M84.HKD","LU0965509283.SGD","GSK.UK","IE00BKDWB100.SGD","LU2111349929.HKD","LU1629891620.HKD","LU1623119135.USD","IE000M9KFDE8.USD","BK7508","BK4566","LU1720051108.HKD","LU2361045086.USD","LU2361044949.HKD","LU0672654240.SGD","LU0072461881.USD","GDOC","LU1718418525.SGD","IXJ","04332","LU1267930730.SGD","LU1894683264.USD","LU0471298777.SGD","IE00BBT3K403.USD","LU0320765992.SGD","LU1923622614.USD","IE00B1XK9C88.USD","SG9999015358.SGD","MEDX","LU2087625088.SGD","LU1934455863.HKD","IE00B19Z9P08.USD","LU2756315318.SGD","IHE","LU0154236417.USD","IE0004445239.USD","LU0321505439.SGD","LU0162691827.USD","LU0545039389.USD","BK4504","LU1670711123.USD","LU2023250843.SGD","LU2023251221.USD","LU2236285917.USD","SGXZ99366536.SGD","LU0203202063.USD","LU2505996509.AUD","LU1059921491.USD","LU1035773651.USD","IE00BKPKM429.USD","SG9999001176.SGD","LU0965509010.AUD","LU0130102774.USD","LU2596442595.SGD","LU1670710661.SGD","IE00B19Z9Z06.USD","LU0211331839.USD","JNJ","LU1069344957.HKD","LU1868836914.USD","LU2129689514.USD","LU2237443549.SGD","IE00BFSS7M15.SGD","LU1720051017.SGD","LU2471134952.CNY","LU2168564222.USD","LU1221951129.SGD","LU2168564065.EUR","LU2433249047.HKD","LU2168564149.EUR","IBBQ","LU0225283273.USD","LU0225284248.USD","LU2746668974.SGD","LU1061106388.HKD","THNR","LU0353189763.USD","LU1244550494.USD","LU0823434740.USD","SG9999018865.SGD","LU0965508806.USD","BK4534","SG9999002232.USD","LU1929549753.HKD","AMGN","LU1116320737.USD","LU0058720904.USD","LU0198837287.USD","LU1829250122.USD","LU2237443895.HKD","LU1323610961.USD","LU0114720955.EUR","LU0345770993.USD","LU2237443465.HKD","LU2087621335.USD","LU1496350502.SGD","LU0345769631.USD","LU0158827948.USD","LU0106261372.USD","LU0708995401.HKD","LU2360032135.SGD","LU1699723380.USD","LU1674673428.USD","IE00BSNM7G36.USD","LU2108987350.USD","SG9999014914.USD","LU0122379950.USD","TBXU","LU2089283258.USD","LU0456855351.SGD","LU1868837136.USD","LU2592432038.USD","LU0868494708.USD","LU2168563687.JPY","LU0795875169.SGD","LU1804176565.USD","BK4139","LU2361044865.SGD","LU0320765646.SGD","LU2237443622.USD","LU2462591350.SGD","IE00B7KXQ091.USD","LU2264538146.SGD","LU0203201768.USD","LU2242652126.USD","LU0432979614.USD","IE00BJJMRZ35.SGD","LU2552382132.HKD","LU0208291251.USD","LU0868494617.USD","IE00B1BXHZ80.USD","LU0203345920.USD","IE0004445015.USD","BMED","SGXZ51526630.SGD","SG9999001440.SGD","LU0094547139.USD","GILD","BK4585","LU1670627923.USD","LU0234572021.USD","LU2242646821.SGD","LU0210536198.USD","BBH","LU0320765489.SGD","LU2417539215.USD","LU0820561818.USD","BK4578","LU0310800379.SGD","CANC","LU1712237335.SGD","LU2237443382.USD","LU1989772923.USD","LU0477156953.USD","LU0354030438.USD","LLY","IE00BVYPNV92.GBP","IE0005OL40V9.USD","LU1066051498.USD","IE0000B7K699.USD","SG9999015952.SGD","LU2125909593.SGD","WDNA","LU1057294990.SGD","LU0965509101.SGD","LU0786609619.USD","BK4583","LLYZ","LU1914381329.SGD","LU0211328371.USD","IE00BJT1NW94.SGD","LU0053666078.USD","LU1894683348.USD","GSKH","NVOX","LU2133065610.SGD","LU0316494557.USD","LU0787776722.HKD","SG9999014575.USD","LU0689472784.USD","BK7511","LU2750360997.AUD","IE00BFSS8Q28.SGD","LU1506573853.SGD","CSL.AU","IE00BFTCPJ56.SGD","OZEM","SG9999018857.SGD","LU0256863811.USD","SG9999014542.SGD","IE00BZ1G4Q59.USD","JDOC","LU2471134796.USD","NVOH","LU1670628061.USD","MHIP","IE00B7SZLL34.SGD","LU0861579265.USD","NVO","LU0306807586.USD","LU2089984988.USD","LU0061475181.USD","BK4599","LU0726765562.USD","IE000SO60NU8.SGD","LU0553294199.USD","IE00B19Z3B42.SGD","LU0238689110.USD","LU0385154629.USD","LU0889566641.SGD","LU0265550359.USD","LU2357305700.SGD","SG9999017495.SGD","LU1267930490.SGD","BK4533","LU2750360641.GBP","LU2430703095.HKD","LU2491050071.SGD","LU1023059063.AUD","LU1670711040.USD","IE00B4JS1V06.HKD","LU1291159041.SGD","IE000WAW04H5.SGD","LU2602419157.SGD","FHLC","IE0002270589.USD","IE00B3T34201.USD","LU0882574139.USD","LU0256863902.USD","LU0417517546.SGD","LU0823434583.USD","LU2430703178.SGD","LU1988902786.USD","IE000F7OJYX1.SGD","LU0070217475.USD","AGNG","LU2265009873.SGD","RXL","AZNH","LU1732800096.USD","IBB","BK7067","IE00BFXG1179.USD","LU0426417589.USD","SG9999015978.USD","LU0310799852.SGD","LU1989771016.USD","BIIB","LU1267930813.SGD","LU1145028129.USD","SG9999015945.SGD","LU1430594728.SGD","PAWZ","GB00BDT5M118.USD","SG9999014567.USD","LU2129689431.USD","MEDI","LU0323591593.USD","LU0203347892.USD","LU1941712264.USD","LU0079474960.USD","LU0128525929.USD","ELIL","LU0648001328.SGD","LU1127390331.HKD","ILDR","LU0472753341.HKD","LU2112291526.USD","LU1674673691.USD","LU0820562030.AUD","BK4007","LU0994945656.USD","LU0889565916.HKD","LU1989772840.SGD","LU1093756325.SGD","LU2347655156.SGD","GLAM","LU1032466523.USD","LU0237698245.USD","LU1983299246.USD","SG9999015341.SGD","LU0683600562.USD","LU1814569148.SGD","IE00BWXC8680.SGD","LU0006306889.USD","LU2106854487.HKD","LU1934455194.USD","LU0912757837.SGD","LU1571399168.USD","BK4550","LU0225771236.USD","SG9999003800.SGD","LU1035775433.USD","LU2324357040.USD","LU0964807845.USD","IE0009355771.USD","SGXZ57979304.SGD","LU0661504455.SGD","TMED","LU2471134879.HKD","LU0069063385.USD","LU2237438978.USD","LU0320765059.SGD","LU1066053197.SGD","TRUH","IE00BJJMRY28.SGD","LU0070302665.USD","LU0109391861.USD","LU0426412945.USD","LU0210528500.USD","LU1196500208.SGD","PPH","FTXH","IE00BLSP4239.USD","LLII","LU0466842654.USD","LU2063271972.USD","ELIS","LU2347655073.USD","LU2213496289.HKD","LU1066051811.HKD","LU1201861249.SGD","LU0985320562.USD","LU2125909247.SGD","LU0980610538.SGD","LU2028103732.USD","BK4588","LU1585245621.USD","LU0345769128.USD","GSK","IE00BVYPNW00.USD","LU0640476718.USD","LU0545562505.USD","LU0289961442.SGD","LU2168564495.EUR","LU0738911758.USD","SGXZ80539844.SGD","PBE","LU1043141396.HKD","LU2505996681.GBP","LU2756315664.SGD","LU2468319806.SGD","LU1074936037.SGD","LU0823416689.USD","LU1366192091.USD","ABBV","LU2552382215.SGD","LU0057025933.USD","IE00BK4W5L77.USD","LU1974910355.USD","LU0289739343.SGD","LU0708994859.HKD","BK4581","IE0002141913.USD","IE0034235303.USD","LU2430703251.USD","LU1839511570.USD","LU2125154778.USD","LU0395794307.EUR","BK7501","LU2023250330.USD","IE00B775H168.HKD","SGXZ31699556.SGD","LU1551013342.USD","LU0234570918.USD","IE00B42XCP33.USD","LU2487616109.SGD","HRTS","LU0158827781.USD","PJP","LU1093756168.USD","LU1670710588.SGD","SG9999014880.SGD","LU1778281490.HKD","IE00B2B36J28.USD","LU1883839398.USD","BIB","LU1979441026.SGD","LU2896262040.SGD","LU2271345857.HKD","LU1244550577.SGD","BK4568","LU2360106947.USD","LU1003077747.HKD","LU1232071149.USD","LU0942090050.USD","LU2471134523.USD","LU0859254822.USD","LU2456880835.USD","IE00B4R5TH58.HKD","LU0985481810.HKD","LU1548497426.USD","IE00BJLML261.HKD","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193258586","title":"新聞稿：Ernexa Therapeutics 引入資深生物技術高管 David Polinsky 加入董事會，為臨床階段衝刺蓄力","url":"https://stock-news.laohu8.com/highlight/detail?id=1193258586","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193258586?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 21:09","pubTimestamp":1786367399,"startTime":"0","endTime":"0","summary":"此次任命正值公司关键转折点，进一步强化了其领导团队——Ernexa 正全力推进其核心项目 ERNA-101，计划于2026年第三季度提交新药临床试验申请，并在第四季度启动首项一期临床研究。马萨诸塞州剑桥市，2026年8月10日——Ernexa Therapeutics，一家致力于开发创新细胞疗法以治疗晚期癌症和自身免疫性疾病的行业先锋，今日宣布任命 David Polinsky 为其董事会成员。“我们正步入 Ernexa 历史上最为重要的时期之一，”Ernexa Therapeutics 总裁兼首席执行官 Sanjeev Luther 表示。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IND","IBB","BK4205","BK4539","XBI","BK4139","RFL","ERNA","BK4585","LENZ","BK4581","BK4588","BBP","SYNB","BK4007","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658398169","title":"Vertex Pharma股價上漲，因競爭對手的遺傳性疾病藥物研發遭遇挫折","url":"https://stock-news.laohu8.com/highlight/detail?id=2658398169","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658398169?lang=zh_tw&edition=fundamental","pubTime":"2026-08-10 20:36","pubTimestamp":1786365394,"startTime":"0","endTime":"0","summary":"BUZZ-Vertex Pharma股价上涨，因竞争对手的遗传性疾病药物研发遭遇挫折8月10日-** 制药公司Vertex Pharmaceuticals（VRTX.O）的股价在盘前交易中上涨7.65%，至534美元** Sionna Therapeutics（SION.O） (link) 表示，由于SION-719实验性囊性纤维化药物在中期临床试验中未能达到主要目标，公司将终止该药物的研发** ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4T4470W0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","IE00B19Z3581.USD","LU0109394709.USD","GNMX","IE00B894F039.SGD","LU2468319806.SGD","IE00B19Z3B42.SGD","LU1778281490.HKD","BIB","LU0417517546.SGD","LU0889565916.HKD","IE0002141913.USD","LU0256863811.USD","LU0061475181.USD","BK4567","IE00BZ9MQY76.HKD","LU0320765992.SGD","BBH","LU2324357040.USD","IE00B4R5TH58.HKD","BK4588","IE00B19Z9P08.USD","VRTX","LU1093756168.USD","SG9999001176.SGD","LU1069344957.HKD","BK4533","LU0058720904.USD","LU2456880835.USD","BK4532","SION","LU1674673691.USD","IBBQ","SG9999001176.USD","LU0432979614.USD","IBB","SGXZ57979304.SGD","LU1035775433.USD","IDNA","LU2236285917.USD","IE00B2B36J28.USD","PBE","SG9999013999.USD","LU2237438978.USD","LU0823416689.USD","TBXU","LU1674673428.USD","LU2462157665.USD","IE0002270589.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}